Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H51O4P |
| Molecular Weight | 434.6331 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCC
InChI
InChIKey=JTXUVYOABGUBMX-UHFFFAOYSA-N
InChI=1S/C24H51O4P/c1-3-5-7-9-11-13-15-17-19-21-23-27-29(25,26)28-24-22-20-18-16-14-12-10-8-6-4-2/h3-24H2,1-2H3,(H,25,26)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of double-tailed surfactant architecture on the conformation, self-assembly, and processing in polypeptide-surfactant complexes. | 2009-10-12 |
|
| Influence of the structure and composition of mono- and dialkyl phosphate mixtures on aluminum complex organogels. | 2009-08-04 |
|
| Temperature and compression rate independent domain shape in Langmuir monolayers of di-n-dodecyl hydrogen phosphate at the air-water interface. | 2008-03-01 |
|
| Interactions of L-arginine with Langmuir monolayers of di-n-dodecyl hydrogen phosphate at the air-water interface. | 2006-12-01 |
|
| Construction and electrochemistry of Langmuir-Blodgett films of fullerene lipid composite/hybrid materials. | 2006-06 |
|
| An enzyme-detergent method for effective prion decontamination of surgical steel. | 2005-03 |
|
| Fourier transform infrared spectroscopic study of the interactions of a strongly antimicrobial but weakly hemolytic analogue of gramicidin S with lipid micelles and lipid bilayer membranes. | 2003-01-21 |
|
| Molecular dynamics simulation of n-dodecyl phosphate aggregate structures. | 2001-09 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1593447
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | RxNorm | ||
|
2614
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | |||
|
7057-92-3
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | |||
|
12427
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | |||
|
9P58XP0JBR
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | |||
|
230-341-2
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | |||
|
23467
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY | |||
|
DTXSID60863996
Created by
admin on Mon Mar 31 22:23:25 GMT 2025 , Edited by admin on Mon Mar 31 22:23:25 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
